BIOTRONIK announces the launch of its new guide wire range Galeo Pro
Designed for both simple and the most challenging procedures
BUELACH, Switzerland, July 18, 2013 – BIOTRONIK launches its next generation of guide wires. Galeo Pro stands out for its properties based on the high tensile stainless steel core: increased durability and excellent shape retention. These allow the physician to treat multiple lesions with one wire, thus increasing safety and saving procedure time. This new generation of the classic Galeo guide wire inherits outstanding torque and trackability from previous models.
"Successful percutaneous coronary intervention (PCI) starts with a good guide wire that you can rely on. A guide wire is certainly one of the most important tools for the physician and in many cases determines the success of the procedure”, explains Dr. hab. med. Krzysztof Reczuch from the 4thMilitaryClinicalHospital inWroclaw,Poland. “Galeo Pro provides excellent characteristics for both simple and challenging procedures. It delivers outstanding support, torque, and lubricity for easy passage through complex anatomies, as well as enabling the smooth delivery of devices.”
Since the launch of its first guide wire back in 1997, BIOTRONIK has become a major provider of guide wires for both coronary and peripheral interventions, offering one of the most comprehensive ranges on the market. “With Galeo Pro, we demonstrate once again our commitment to delivering a complete range of innovative, high quality solutions for the interventional cardiologist”, explains Dr. Alexander Uhl, BIOTRONIK Vice President Marketing, Vascular Intervention.
Galeo Pro will be available with varying tip flexibility, shape, length and support, making it a true workhorse guide wire, suitable for the most simple to the most challenging clinical cases.
Communications & PR Manager
BIOTRONIK SE & Co. KG
Tel. 49 (0) 30 68905 1466
About BIOTRONIK SE & Co. KG
As one of the world’s leading manufacturers of cardiovascular medical devices, BIOTRONIK is headquartered in Berlin, Germany, and represented in over 100 countries by its global workforce of more than 5,600 employees. Several million heart patients around the world have received BIOTRONIK implants, designed to save and improve the quality of their lives. Since its development of the first German pacemaker in 1963, BIOTRONIK has launched several innovations into the market—including remote monitoring with BIOTRONIK Home Monitoring®in 2000 and the world’s first implantable cardioverter-defibrillators and implantable heart failure therapy devices with ProMRI®technology, approved for MR scanning, in 2012. This year BIOTRONIK is celebrating its 50th anniversary.